Cardio Parma 2026 – 5th edition

CardioParma 2026, now in its 5th edition, confirms its role as a meeting dedicated to advanced and integrated cardiovascular care. The congress is designed to promote dialogue between cardiology and cardiac surgery through a multidisciplinary scientific program focused on innovation, clinical practice, and shared decision-making.

The modern management of cardiovascular disease requires an increasingly coordinated approach. Patients are more complex, clinical scenarios are more challenging, and treatment pathways must be tailored to individual needs. In this setting, collaboration between different specialists is essential. CardioParma aims to strengthen this perspective by offering a forum in which expertise, technologies, and treatment strategies can be discussed in a practical and interactive way.

The 2026 edition will address the major areas of interest in contemporary cardiovascular medicine. Prevention will be one of the central themes, with attention to cardiometabolic risk, lipid disorders, inflammation, obesity, and environmental determinants of cardiovascular disease. The program will also focus on ischemic heart disease, with discussion of coronary risk assessment, chronic ischemic syndromes, and the evolving role of both interventional and surgical revascularization.

Special emphasis will be placed on valvular heart disease. Dedicated sessions will examine aortic, mitral, and tricuspid valve disorders from diagnostic evaluation to treatment selection. Imaging, transcatheter procedures, conventional surgery, minimally invasive techniques, and lifetime management strategies will be discussed with the aim of identifying the most appropriate option for each patient.

The congress will also provide an update on cardiomyopathies, pulmonary hypertension, and heart failure. These sessions will cover new drugs, genetic evaluation, cardiogenic shock, advanced heart failure therapies, mechanical circulatory support, and heart transplantation. The overall objective is to offer a contemporary view of personalized management in highly specialized cardiovascular settings.

Further sessions will be dedicated to thoracic aortic disease and arrhythmias, with particular attention to risk stratification, surgical and endovascular treatment, device therapy, catheter ablation, and the integration of guideline recommendations into daily practice.

Through lectures, expert discussions, and direct comparison between different specialties, CardioParma 2026 aims to provide a rigorous and up-to-date scientific exchange. The participation of distinguished Italian and international faculty will further enrich the educational value of the meeting.